|
Volumn 13, Issue 4, 2002, Pages 1017-1024
|
The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM CHANNEL STIMULATING AGENT;
CINACALCET;
PLACEBO;
UNCLASSIFIED DRUG;
VITAMIN D;
ADULT;
AGED;
ARTICLE;
BLOOD VESSEL CALCIFICATION;
CALCIUM BLOOD LEVEL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
HEMODIALYSIS;
HUMAN;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MINERAL METABOLISM;
MULTICENTER STUDY;
PARATHYROID HORMONE BLOOD LEVEL;
PARATHYROID HORMONE RELEASE;
PHOSPHATE BLOOD LEVEL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SECONDARY HYPERPARATHYROIDISM;
|
EID: 0036208986
PISSN: 10466673
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (252)
|
References (25)
|